Old Web
English
Sign In
Acemap
>
authorDetail
>
Yumiko Kajimoto
Yumiko Kajimoto
Takeda Pharmaceutical Company
Renin inhibitor
Renin–angiotensin system
Aliskiren
Plasma renin activity
Pharmacology
3
Papers
27
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.
2018
Bioorganic & Medicinal Chemistry
Hidekazu Tokuhara
Yasuhiro Imaeda
Yoshiyuki Fukase
Koichi Iwanaga
Naohiro Taya
Koji Watanabe
Ray Kanagawa
Keisuke Matsuda
Yumiko Kajimoto
Keiji Kusumoto
Mitsuyo Kondo
Gyorgy Snell
Craig A. Behnke
Takanobu Kuroita
Show All
Source
Cite
Save
Citations (4)
TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.
2018
PLOS ONE
Tomoya Hara
Satoshi Nishimura
Toshihiro Yamamoto
Yumiko Kajimoto
Keiji Kusumoto
Ray Kanagawa
Shota Ikeda
Tomoyuki Nishimoto
Show All
Source
Cite
Save
Citations (5)
Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor.
2016
ACS Medicinal Chemistry Letters
Yasuhiro Imaeda
Hidekazu Tokuhara
Yoshiyuki Fukase
Ray Kanagawa
Yumiko Kajimoto
Keiji Kusumoto
Mitsuyo Kondo
Gyorgy Snell
Craig A. Behnke
Takanobu Kuroita
Show All
Source
Cite
Save
Citations (18)
1